Return
Aptamer targeting HMGB1 attenuates inflammatory disease via domain-specific antagonism
DOI:10.1016/j.chembiol.2026.06.011.png)
Abstract
En 中文
• A high-affinity DNA aptamer targets the proinflammatory B-box of HMGB1 • Extracellular HMGB1 is neutralized, suppressing inflammatory signaling • Organ injury is reduced in endotoxemia, and survival improves in polymicrobial sepsis • Methotrexate efficacy is enhanced in chronic inflammatory arthritis
Journal
IF:
7.2
Papers:
1.7K
Citations:
9.1K
Organization
U

